MiMedx Group, Inc. (NASDAQ:MDXG – Get Free Report) has been given a consensus rating of “Buy” by the four ratings firms that are covering the company, MarketBeat.com reports. Four investment analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokerages that have issued ratings on the stock in the […]